November 30, 2023
- May 5, 2021 - NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional). See NOFO PAR-21-224.
National Institute of Neurological Disorders and Stroke (NINDS)
The purpose of this notice is to inform applicants of an extension to PAR-21-224 "NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)". This notice of funding opportunity (NOFO) has been extended by one additional council round (September 5, 2024 due date and September 6, 2024 expiration date). Changes to the NOFO are shown below.
Changes to NOFO are shown below:
Currently Reads:
Part 1. Overview Information
Key Dates:
| Application Due Date(s) | Standard dates apply *** Note new SBIR/STTR Standard Due Dates. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
| Scientific Merit Review | Standard dates apply |
| Advisory Council Review | Standard dates apply |
| Earliest Start Date | Standard dates apply |
| Expiration Date | April 06, 2024 |
Modified to Read:
Part 1. Overview Information
Key Dates:
| Application Due Date(s) | Standard dates apply *** Note new SBIR/STTR Standard Due Dates. All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. |
| Scientific Merit Review | Standard dates apply |
| Advisory Council Review | Standard dates apply |
| Earliest Start Date | Standard dates apply |
| Expiration Date | September 6, 2024 |
All other aspects of this NOFO remain unchanged.
Sophie Cho, MD
National Institute of Neurological Disorders and Stroke (NINDS)
Tel: 301-529-7157
[email protected]
Joan Ohayon
National Institute of Neurological Disorders and Stroke (NINDS)
Tel: 301-814-2977
[email protected]
and Human Services (HHS)
